Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh
TAJ: Journal of Teachers Association · 01.06.2026 · 39 (2) · 195-201
DOI: 10.70818/taj.v39i2.0680 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift TAJ: Journal of Teachers Association, online erschienen am 01.06.2026. Verfasst von Mohammad Tariqul Islam und 6 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is associated with dysregulation of vitamin D metabolism and mineral homeostasis. Reduced renal activation of vitamin D leads to decreased circulating levels of 1,25-dihydroxyvitamin D and contributes to CKD-mineral and bone disorder (CKD-MBD). Understanding changes in active vitamin D levels across CKD stages may help identify metabolic complications associated with disease progression.
Objective
To assess the serum levels of 1,25-dihydroxyvitamin D in patients with chronic kidney disease (CKD) stages G3-G5 and to assess its correlation with other laboratory parameters.
Methods
This cross-sectional observational study was conducted in the Department of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh, from April to December 2020. A total of 75 patients with CKD stages G3–G5 were selected using purposive sampling. Clinical and laboratory data were collected from medical records and a semi-structured questionnaire. Serum 1,25-dihydroxyvitamin D and other biochemical parameters were analyzed. Independent sample t-test, one-way ANOVA, and Pearson correlation tests were used for statistical analysis.
Results
The mean serum 1,25-dihydroxyvitamin D level was 26.00 ± 16.45 pg/mL. A progressive decline in serum 1,25-dihydroxyvitamin D levels was observed with advancing CKD stage. Mean levels were 32.78 ± 18.67 pg/mL in stage G3, 29.33 ± 16.27 pg/mL in stage G4, and 18.37 ± 10.17 pg/mL in stage G5, showing a statistically significant difference among stages (p = 0.007). Serum 1,25-dihydroxyvitamin D demonstrated a significant positive correlation with eGFR (r = 0.415, p < 0.001) and 25-hydroxyvitamin D (r = 0.259, p = 0.031).
Conclusion
Serum 1,25-dihydroxyvitamin D levels decreased significantly with increasing CKD stage and were closely associated with kidney function and phosphorus metabolism. Dynamic monitoring of active vitamin D may help to identify CKD-MBD-related metabolic disorders in an early stage.
Zitieren
APA
Islam, M. T., Iqbal, M., Roy, S. C., Ali, M., Shahid, S. N., Salauddin, S. M., & Bashar, M. A. (2026). Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh. TAJ: Journal of Teachers Association, 39(2), 195-201. https://doi.org/10.70818/taj.v39i2.0680
Vancouver
Islam MT, Iqbal M, Roy SC, Ali M, Shahid SN, Salauddin SM, et al. Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh. TAJ: Journal of Teachers Association. 2026;39(2):195-201. doi:10.70818/taj.v39i2.0680
BibTeX
@article{Islam2026,
author = {Islam, Mohammad Tariqul and Iqbal, Masud and Roy, Suman Chandra and Ali, Maleka and Shahid, Samawat Naiyer and Salauddin, Sarif Mahammad and Bashar, Md Afzalul},
title = {Serum 1,25-Dihydroxyvitamin D Levels Across Stages of Chronic Kidney Disease: A Cross-Sectional Study in Bangladesh},
journal = {TAJ: Journal of Teachers Association},
year = {2026},
volume = {39},
number = {2},
pages = {195--201},
doi = {10.70818/taj.v39i2.0680}
}
EUVIMED